190 related articles for article (PubMed ID: 8630391)
1. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.
Jesty J; Lorenz A; Rodriguez J; Wun TC
Blood; 1996 Mar; 87(6):2301-7. PubMed ID: 8630391
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity.
Rao LV; Nordfang O; Hoang AD; Pendurthi UR
Blood; 1995 Jan; 85(1):121-9. PubMed ID: 7803789
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
5. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
[TBL] [Abstract][Full Text] [Related]
8. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.
Ott I; Miyagi Y; Miyazaki K; Heeb MJ; Mueller BM; Rao LV; Ruf W
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):874-82. PubMed ID: 10712416
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor (TFPI)--an update.
Sandset PM
Haemostasis; 1996 Oct; 26 Suppl 4():154-65. PubMed ID: 8979119
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line.
Hamamoto T; Foster DC; Kisiel W
Int J Hematol; 1996 Jan; 63(1):51-63. PubMed ID: 8713577
[TBL] [Abstract][Full Text] [Related]
11. The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III.
Hamamoto T; Kisiel W
Int J Hematol; 1998 Jul; 68(1):67-78. PubMed ID: 9713170
[TBL] [Abstract][Full Text] [Related]
12. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor.
Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L
J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255
[TBL] [Abstract][Full Text] [Related]
13. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
Jesty J; Wun TC; Lorenz A
Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
[TBL] [Abstract][Full Text] [Related]
15. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI.
Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI
J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386
[TBL] [Abstract][Full Text] [Related]
16. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
van 't Veer C; Golden NJ; Mann KG
Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
[TBL] [Abstract][Full Text] [Related]
19. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface.
Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV
J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304
[TBL] [Abstract][Full Text] [Related]
20. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
